ストックスクリーナーアプリを入手
2.75
0.36%
-0.010
Nuvation Bio Inc (NUVB) 最新ニュース
Why Nuvation Bio Inc. stock attracts strong analyst attentionJuly 2025 Gainers & Verified High Yield Trade Plans - thegnnews.com
Detecting support and resistance levels for Nuvation Bio Inc.2025 Analyst Calls & Risk Adjusted Swing Trade Ideas - Newser
What institutional flow reveals about Nuvation Bio Inc.Portfolio Value Report & Low Drawdown Trading Strategies - Newser
Nuvation Bio Inc. stock outlook for YEARLayoff News & Growth Focused Stock Reports - Newser
XTX Topco Ltd Buys 44,979 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
What MACD signals say about Nuvation Bio Inc.July 2025 Price Swings & Capital Efficient Trade Techniques - Newser
Does Nuvation Bio Inc. show high probability of reboundJuly 2025 Patterns & Verified Chart Pattern Trade Signals - Newser
Nuvation Bio's Breakthrough FDA-Approved Iprozy and Its Implications for Biotech Growth - AInvest
Transcript : Nuvation Bio Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Exit strategy if you’re trapped in Nuvation Bio Inc.Volume Spike & Fast Exit Strategy with Risk Control - Newser
Chart Patterns Forming a Bullish Setup in Nuvation Bio Inc.2025 Valuation Update & Reliable Price Breakout Signals - kangso.co.kr
Nuvation Bio’s SWOT analysis: stock poised for growth amid challenges - Investing.com
Technical analysis overview for Nuvation Bio Inc. stockPortfolio Risk Summary & Daily Volume Surge Signals - Newser
Nuvation Bio (NUVB.N) Spikes 11.6% Intraday: A Deep Dive Into the Unusual Move - AInvest
Nuvation Bio (NUVB.N) Surges 12.5%—What’s Fueling the Move? - AInvest
Analyzing recovery setups for Nuvation Bio Inc. investorsCEO Change & Free Community Consensus Stock Picks - Newser
Tools to monitor Nuvation Bio Inc. recovery probabilityChart Pattern Strategy with ROI Focus - Newser
Nuvation Bio Inc. (NYSE:NUVB) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates - 富途牛牛
Nuvation Bio (NYSE:NUVB) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says - Defense World
Nuvation Bio Inc. (NUVB) Reports Q2 Loss, Beats Revenue Estimates - MSN
Wall Street Zen Downgrades Nuvation Bio (NYSE:NUVB) to Sell - Defense World
Nuvation Bio shares rise 1.30% after-hours after RBC raised its price target to $7. - AInvest
Nuvation Bio’s Phase 2 Study on Safusidenib: A Potential Game-Changer for IDH1 Mutant Glioma - TipRanks
RBC Raises Price Target on Nuvation Bio to $7 From $6, Keeps Outperform, Speculative Risk - MarketScreener
Nuvation Bio Sees Rapid Adoption of IBTROZI, Reports $1.2M in Q2 2025 Sales and $607.7M in Cash Reserves. - AInvest
Nuvation Bio Reports Second Quarter 2025 Financial Results and Provides Business Update - BioSpace
Nuvation Bio Inc (NUVB) Q2 2025 Earnings Call Highlights: Strong IBTROZI Launch and Strategic ... By GuruFocus - Investing.com Canada
Nuvation Bio’s Milestone with FDA Approval of IBTROZI - TipRanks
NUVB Sales Jump 1,043% on Drug Launch - AOL.com
Nuvation Bio Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Nuvation Bio Reports 1,043% YoY Sales Growth, Exceeds Revenue Estimates with $4.8 Million in GAAP Revenue - AInvest
Earnings call transcript: Nuvation Bio Q2 2025 sees steady EPS, stock rises - Investing.com
Nuvation Bio Inc. SEC 10-Q Report - TradingView
Nuvation Bio earnings matched, revenue topped estimates By Investing.com - Investing.com Canada
Earnings Flash (NUVB) Nuvation Bio Inc. Reports Q2 Revenue $4.8M - MarketScreener
New Lung Cancer Drug IBTROZI Gains FDA Approval, Reaches 70 Patients in First 7 Weeks - Stock Titan
Nuvation Bio To Present New Data on IBTROZI™ (taletrectinib) in Advanced ROS1-Positive Non-Small Cell Lung Cancer at WCLC and ESMO Annual Congresses - BioSpace
Nuvation Bio Presents New IBTROZI Data at WCLC and ESMO Congresses - AInvest
What are the latest earnings results for Nuvation Bio Inc.Consistent triple-digit returns - Jammu Links News
What makes Nuvation Bio Inc. stock price move sharplyCapitalize on market trends with confidence - Jammu Links News
Nuvation Bio Inc. Stock Analysis and ForecastDiscover undervalued stocks before they soar - Jammu Links News
Nuvation Bio (NUVB.N) Plunges 5.5%: What’s Behind the Sudden Sell-Off? - AInvest
Nuvation Bio Announces Q2 2025 Financial Results and Business Update on August 7, 2025. - AInvest
What catalysts could drive Nuvation Bio Inc. stock higher in 2025Get real-time alerts on top-performing stocks - Jammu Links News
Nuvation Bio (NUVB.N) Drops 5.5%: What’s Behind the Sudden Slide? - AInvest
How does Nuvation Bio Inc. generate profit in a changing economyFree Investment Case Studies - Jammu Links News
How does Nuvation Bio Inc. compare to its industry peersFree Trend-Following Techniques - Jammu Links News
Is Nuvation Bio Inc. a good long term investmentExceptional financial outcomes - Jammu Links News
What institutional investors are buying Nuvation Bio Inc. stockConsistent wealth multiplication - Jammu Links News
Is Nuvation Bio Inc. a growth stock or a value stockInvest in stocks with long-term growth potential - Jammu Links News
RBC Capital Maintains a Buy on Nuvation Bio (NUVB) With a $6 PT - MSN
What is the dividend policy of Nuvation Bio Inc. stockBreakout portfolio performance - Jammu Links News
What markets is GLXG expanding into Is Nuvation Bio Inc. stock a good long term investment optionUnlock powerful portfolio management tools - Jammu Links News
Quant Models Detect Momentum Reversal in Nuvation Bio Inc.AI Forecast for Trending Stocks Indicates Upside - beatles.ru
Nuvation Bio (NUVB)’s Taletrectinib Selected as Preferred Agent for Cancer Treatment - Insider Monkey
0.41%
0.88%
大文字化:
|
ボリューム (24 時間):